Reuters | 2 hours ago
Just 30 percent of Americans living with HIV have the virus in check, putting others at risk of infection, U.S. health officials said yesterday. The report by the U.S. Centers for Disease Control and Prevention (CDC) found that 840,000 of the 1.2 million people infected with HIV in 2011 were not consistently taking anti-HIV drugs that keep the virus suppressed at very low levels.
Huffington Post | 2 hours ago
Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."
Hepatitis C transmission and prevention
Cherwell | 2 hours ago
A new vaccine developed by researchers at the University of Oxford has generated a strong immune response against the Hepatitis C virus in human volunteers. The vaccine is the first Hepatitis C inoculation to reach this stage of clinical trials, and the results have been promising. The 15 healthy human volunteers who took part in the phase 1 safety trial all responded positively.The study found that after the second, booster inoculation, all 15 volunteers had large, broad and sustained T cells responses.
Epidemiology and behaviour
South China Morning Post | 3 hours ago
A total of 195 new HIV cases were reported Hong Kong in the third quarter of the year, the highest number ever in a single quarter, Hong Kong's Centre for Health Protection said yesterday, while a separate survey found that the infection rate among gay men had risen almost two percentage points. More than 85 per cent of new HIV cases were in men, most aged from 20 to 29. HIV prevalence in gay men has risen from 4.1% to 5.9% - a 44% increase in a single year - though this new estimate may partly be due to more people coming forward to be tested.
Epidemiology and behaviour
HELLENIC CENTER FOR DISEASE CONTROL AND PREVENTION | 3 hours ago
Health authorities in Greece say the number of HIV infections fell in 2013 for the first time since the start of the financial crisis. In its annual report issued Tuesday, Greece's Center for Disease Control and Prevention said the number of new infections nationwide fell by 20%, from 920 last year from 1,188 in 2012. This is largely due to a 52% decline in infections in people who inject drugs after a sharp spike in infections in 2012.
New and experimental HIV treatments
Janssen | 17 hours ago
Janssen-Cilag International NV (Janssen) today announced that the European Commission (EC) has approved the use of REZOLSTA ® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus - 1 (HIV - 1) infection in adults aged 18 years or older. "REZOLSTA ® eliminates the need to take a boosting agent in a separate tablet with once - daily darunavir, reducing the pill burden for patients," said Christiane Moecklinghoff, M.D Ph.D, Medical Director, Virology, Janssen EMEA.
Injecting drug use
The Guardian | 19 hours ago
Handing the reins to the Department of Health might seem a liberal-minded approach, but it could mean less is spent on treatment. Drug use simply doesn’t cause as much ill-health as other risky behaviours, so isn't prioritised by health officials. But it is seen as a major cause of crime.
Testing policies and guidelines
MEDFASH press release | 20 hours ago
With a quarter of the estimated 108,000 people living with HIV in the UK still going undiagnosed, MEDFASH has developed HIV Testing in Practice (HIV TIPs), an online educational tool, to help increase rates of HIV diagnosis in primary care. Launched in National HIV Testing Week, the interactive webtool will enable GPs, practice nurses and their teams to raise their knowledge of HIV and enhance their confidence in offering HIV testing.
The Body | 23 hours ago
Have you heard of the START (Strategic Timing of Antiretroviral Treatment) study? In my opinion, it is probably the most important study currently running. It generates strong views, both for and against initiating antiretroviral therapy early, but the results are likely to be surprising.
HIV prevention policy
The Conversation | 25 November 2014
Two years ago, the “beginning of the end” of AIDS was announced. It included the promise of reducing HIV transmission by reducing the amount of infectious virus in the population. But disease control will fail unless we understand and plan for its translation within complex and adaptive systems. People take up technologies and use them in unanticipated ways. Cultures develop resistance in the same way that bacteria do. We will only ever approach the beginning of the end of AIDS if and when we bear these things in mind.